Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib in Rheumatoid Arthritis
NCT01208181Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Sep 2010
- Primary completion
- Jun 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of etoricoxib in rheumatoid arthritis (RA), sponsored by Organon & Co.. Started Sep 2010; status: completed.
02
Drugs
etoricoxib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01208181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01208181.